CoreCap Advisors’s Definitive Healthcare DH Stock Holding History

CoreCap Advisors’s Portfolio DH Stock Details DH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-56	Closed	-$162	–	2890
2025 Q1	$162	Sell	56 -117	-68%	-$475	﹤0.01%	3017
2024 Q4	$711	Buy	+173	New	+$756	﹤0.01%	2429

Other funds holding DH

Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CoreCap Advisors's DH Position: Q2 2025 in Review

CoreCap Advisors sold out of Definitive Healthcare (DH) in Q2 2025, closing a stake of 56 shares — an estimated $162 sold.

CoreCap Advisors first reported a position in DH in Q4 2024 and held it in 2 quarters. The position peaked at $711 in Q4 2024. 121 funds tracked by Wall St. Rank hold DH as of Q2 2025.

CoreCap Advisors reported no remaining Definitive Healthcare position as of Q2 2025 after selling out during the quarter.
CoreCap Advisors sold 56 Definitive Healthcare shares in Q2 2025, an estimated $162.
CoreCap Advisors first reported a position in Definitive Healthcare in Q4 2024 and held it in 2 quarters.
CoreCap Advisors's Definitive Healthcare position peaked at $711 in Q4 2024.
121 funds tracked by Wall St. Rank held Definitive Healthcare as of Q2 2025.

Based on CoreCap Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.